Khoo, B;
              
      
            
                Tan, T;
              
      
            
                Clarke, SA;
              
      
            
                Mills, EG;
              
      
            
                Patel, B;
              
      
            
                Modi, M;
              
      
            
                Phylactou, M;
              
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
            ... Dhillo, WS; + view all
            
          
      
        
        
        
    
  
(2020)
  Thyroid function before, during and after COVID-19.
The Journal of Clinical Endocrinology & Metabolism
      
    
    
    
         10.1210/clinem/dgaa830.
   (In press).
  
       
    
  
| Preview | Text Khoo_dgaa830.pdf - Accepted Version Download (1MB) | Preview | 
Abstract
Context: The effects of COVID-19 on the thyroid axis remain uncertain. Recent evidence has been conflicting, with both thyrotoxicosis and suppression of thyroid function reported. Objective: We aimed to detail the acute effects of COVID-19 on thyroid function and determine if these effects persisted upon recovery from COVID-19. Design: Cohort observational study. Participants and setting: Adult patients admitted to Imperial College Healthcare National Health Service Trust, London, UK with suspected COVID-19 between March 9 to April 22, 2020 were included, excluding those with pre-existing thyroid disease and those missing either free thyroxine (FT4) or TSH measurements. Of 456 patients, 334 had COVID-19 and 122 did not. Main Outcome Measures: TSH and FT4 measurements at admission, and where available, those taken in 2019 and at COVID-19 follow-up. Results: Most patients (86·6%) presenting with COVID-19 were euthyroid, with none presenting with overt thyrotoxicosis. Patients with COVID-19 had a lower admission TSH and FT4 compared to those without COVID-19. In the COVID-19 patients with matching baseline thyroid function tests from 2019 (n=185 for TSH and 104 for FT4), both TSH and FT4 were reduced at admission compared to baseline. In a complete cases analysis of COVID-19 patients with TSH measurements at follow-up, admission and baseline (n=55), TSH was seen to recover to baseline at follow-up. Conclusions: Most patients with COVID-19 present with euthyroidism. We observed mild reductions in TSH and FT4 in keeping with a non-thyroidal illness syndrome. Furthermore, in survivors of COVID-19, thyroid function tests at follow-up returned to baseline.
| Type: | Article | 
|---|---|
| Title: | Thyroid function before, during and after COVID-19 | 
| Location: | United States | 
| Open access status: | An open access version is available from UCL Discovery | 
| DOI: | 10.1210/clinem/dgaa830 | 
| Publisher version: | https://doi.org/10.1210/clinem/dgaa830 | 
| Language: | English | 
| Additional information: | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | 
| Keywords: | COVID-19, SARS-CoV-2, thyroid function, thyroid gland | 
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine | 
| URI: | https://discovery.ucl.ac.uk/id/eprint/10115014 | 
Archive Staff Only
|  | View Item | 
 
                      
